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Introduction
Since the late 1940s, breast cancer has
been the leading cause of cancer death
among American women. It is estimated
that in 1982, 37,000 deaths from this dis
ease will be recorded, and that 112,000
new cases will be diagnosed.'
The epidemiology of breast cancer has
been the subject of investigation since be
fore the 1930s,2 and studies have prolif
erated since the 1960s. By the end of 1979.
close to 400 articles had been written on
the subject, including a number of com
prehensive reviews. 3-6This massive amount
of investigation has established a number
of widely accepted risk factors for this dis
ease, which have been documented with
a fair degree of consistency. These include
a family history of breast cancer; nullip
arity; late age at first live birth; early age
at menarche; late age at menopause; his
tory of benign breast disease; high socio
economic status; high-dose radiation ex
posure; and being single, Jewish, or
obese 3-22
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In addition, many experts have be
lievedthata diethighinanimalfatsand
perhaps dairy products or a diet low in
fiber is associated with an elevated risk of
breast cancer.23-29 For many reasons, epi
demiologic confirmation of this hypothesis
has been difficult to obtain.'0
More recently, several heretofore un
recognized associations between certain
factors and breast cancer development
have been uncovered and await further
confirmation. These include alcohol con
sumption, long-term estrogen replacement
therapy, tonsillectomy, and abortion dur
ing first trimester of pregnancy.3-37 Con
troversy still surrounds the estimates of the
risk of breast cancer related to long-term
use of oral contraceptives, hair dyes, and
some antihypertensive medication. â€œ¿S-s'
The variety of factors and multitude
of possible combinations make it ex
tremely difficult to identify specific factors
that predict the development of this disease
in individuals. For example. most of the
identified risk factors can be indicated in
a number of different forms or combina
tions: being single as a reflection of nul
liparity; consuming a high-fat diet as a re
flection or extension of high socioeconomic
status; use of hair dye as an indicator of
social class; diets high in animal fats or
milk reflecting a low intake of fiber; high
parity indicating early age at first birth.
Sorting out these independent and possibly
confounding factors is one of the many
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difficult tasks faced by epidemiologists.
While epidemiologic studies continue
to be conducted and models and mecha
nisms of pathogenesis are being explored.
the fact remains that one out of 11 U.S.
women will develop breast cancer during
her lifetime.â€•0The magnitude of the prob
1cm with its psychological and clinical
ramifications makes it imperative that we
accelerate our efforts in developing prac
tical means of identifying high-risk women
and providing them with some assistance.
This paper will describe the proportion of
the total breast cancer burden carried by
high-risk women and alert clinicians to the
fact that even women without the â€œ¿ac
ceptedâ€• risk factors are at risk of devel
oping the disease.
Materials and Methods
We undertook an analysis of the contri
bution each common risk factor made to
the total risk experienced by more than
570,000 white American women enrolled
in the American Cancer Society's large
scale prospective study begun in 1959.
Study enrollment was made according
to â€˜¿@households.â€•Participation was re
stricted to persons 30 years old or older
who lived in a household in which at least
one person 45 or older was also enrolled
in the study. Participants completed a base
line questionnaire between October 1959
and February 1960. In addition to demo
graphic questions. questions were asked
pertaining to occupation. dietary habits,
medical and family histories, breast dis
ease. operations. parity, and lactation ex
periences. (For a more detailed description
of the questions asked on the original ques
tionnaire. see reference 61.)
Follow-up information was obtained
from nearly all subjects (more than 98 per
cent of the subjects enrolled were traced
for 12 years). Supplementary data were
collected from questionnaires mailed to
women in 1961. 1963. 1965. and 1972.
These included information on whether
they had had a breast operation during the
intervening years and the reason for and
date of operation. Many analyses of these
data have been published.'4 â€œ¿â€˜â€œ@
A total of 571 .716 white women aged
30 and over were enrolled in the study and
followed for six years. Of this group.
9.429 reported breast cancer at entry and
are excluded. The current analysis is fur
ther restricted to 365.812 white women
aged 30 to 84. or 64 percent of those orig
inally enrolled. Because women aged 85
yearsorolderrepresentedonly0.7percent
of the total women, and because their con
tribution to the rates of breast cancer was
minimal, they were dropped from the cal
culations. Also excluded from the sample
were women for which any of the follow
ing conditions obtained:





â€¢¿alcoholic beverage information omitted




â€¢¿menopause information missing for
women 50 yearsoldorolder
â€¢¿history of a surgical menopause.
Of thestudygroup.a totalof 3.130
new cases of breast cancer were reported
forthewomen duringthesix-yearstudy
period: 14 percent of these were deter
mined through death certificates only.
The women weregroupedintofiveage
categoriesforanalyses:30 to44.45 to54.
55 to 64. 65 to 74. and 75 to 84. The data
were collapsedintotwo groups(30to54
and 55 to 84) forpresentationf results
becauseof thewell-knowndifferentialin
riskforpremenopausaland postmenopau
sal women.â€•@â€•9Incidence rates were stan
dardized for age to the distribution of
the total study group within the age inter
vals 30 to 54 and 55 to 84. Frequencies of
cancer in various risk indicator groups were
computed directly.
The majority of the women (64 per
cent) were between the ages of 30 and 54.
withclosetotwo thirdsoftheseinthe45-
to-54 age group. (Because of the enroll
ment criteria, described above, there was
a large proportion of the population en
rolled at ages 45 to 49 compared with ages
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High Risk Low Risk
Historyof breastcancerinmother
and/or sister
History of breast surgery for a
nonmalignant breast condition
Jewish
Menopause atage50 or older
Menarche beforeage 12
Never married
First live birth at 30 years of age
or older, or no live birth
College graduate *
Daily alcohol consumption
(wine, beer, or hard liquor)
Relative weight index 110 or more** *




Menopause before age 50
Menarche at age 12 or older
Ever married
First live birth before age 30
Did not graduate from college
No daily alcohol consumption
Relative weight index less than 110
â€˜¿Asan indicator of benign breast aisease.
â€¢¿â€˜¿Asan indicator of socioeconomic status.
â€¢¿@@@finedas 10 percent or more above average weight for a given woman's
height and age.
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40 to 44.) Among the women aged 55 to
84. the majority (63 percent) were between
the ages of 55 and 64.
Of the many risk factors known to be
related to the development of breast can
cer. 10 were chosen for the current anal
ysis. With the exception of alcohol con
sumption. these are factors that most
investigators consider major predictors of
breast cancer risk. These factors were
treated as dichotomous variables: women
were classified as being in a high-risk or
low-risk group according to the presence
or absence of the risk factor (Table I).
A combination of dietary factors was
originally included in the risk factor anal
vses. but was discarded once it was shown
that the combination did not discriminate
well enough between groups. That is,
when high risk was defined using an index
composed of the regular consumption of
fried foods. eggs. meat. or poultry: use of
fat for cooking: and/or daily milk con
sumption. close to 70 percent of women
in both age groups fell into this risk cat
egory. and there was very little difference
in risk estimates between these women and
others.Othercombinationsof dietaryin
formation yielded similar results. Thus. it
was decided not to consider diet as a risk
factor for this analysis.
Results
Table 2 shows thenumber of women in
each of two broad age groups. 30 to 54
and 55 to 84. according to the number of
risk factors observed. More than 25 per
cent fell into the no-risk-factor category.
according to our definition. About two
thirds of the women had either one or two
risk factors, and the remainder had three
or more. The average number of risk fac
tors per woman in the younger group was
1.4 and in the older group was 1.3.
Table 2 shows the relative and attrib
utable risk for each group of women. The
relative risk (RR) is the ratio of the age
standardized incidence rate in a given
group. divided by the incidence among the
group having no risk factors. As expected.
the RR increases with the number of risk
factors (one, two, three. and four or more):
the RR is higher in the older group than
in the younger group. because the specific
risk factors are different (see below).
The secondfiguregiveninTable2 is
the so-called attributable risk percent.
AR%. the proportion of breast cancers
in the entire population that are asso
ciated with the given risk factors. It is
calculated as: AR% = @e(RR@ â€”¿1) Â±
Eve-(RR. â€”¿I) + 11 X 100% where @e
is the proportion of that group â€œ¿exposedâ€•
to or possessing the risk factor. RR is the
relative risk for breast cancer in the group
being considered. = specific subcate
gories of risk factors. and * = total of one
or more risk factors.
Despite our efforts to
determine risk factors for breast
cancer, we have not appreciably
increased our ability to identify
substantial numbers of truly
high-risk women.
Thus. for example. the largest iden
tifiable contribution to the total breast can
cer incidence in women 55 to 84 years old
comes from women with exactly two risk
factors (10.4 percent of all breast cancers
in this age group). even though numeri
cally there are more women with only one
risk factor.
In the 30-to-54-year-old women, the
largest attributable risk is 7.9 percent, also
in the two-risk-factor group. This means
that 7.9 percent of all breast cancers in 30-
to-54-year-old women can be identified or
attributed to the small group of women
(22.8 percent) who possess exactly two
risk factors (regardless of which factors
they are). It means as well that if all risk
factors were absent in this group of women,
the total number of breast cancers in the




in the 35-to-54 age group would be pre
vemited if all the risk factors in this small
group of double-risk-factor women were
304 CA-A CANCER JOURNAL FOR CLINICIANS
 by on S
eptem












Number Number Percent Cases of Annual
of Risk of of Breast Incidence
Factors Women Women Cancer (per iO@) RR AR
Ages 30-54
None 68,024 29.1 387 12. 1.00 0.0
One 89,872 38.4 601 134.8 1.19 5.7
Two 53,248 22.8 423 163.0 1.44 7.9
Three 17,961 7.7 176 209.9 1.86 5.2
Four or more 4,618 2.0 58 279.1 2.47 2.3
Total,
one or more 165,699 70.9 1,258 155.3 1.38 21.1
Total 233,723 100.0 1,645 142.8
Ages 55-84
None 33,539 25.4 264 120.2 1.00 0.0
One 48,818 36.9 500 154.6 1.29 7.6
Two 32,715 24.8 419 191.6 1.59 10.4
Three 13,036 9.9 230 263.5 2.19 8.4
Four or more 3,981 3.0 72 264.1 2.20 2.6
Total,
one or more 98,550 74.6 1,221 186.4 1.55 29.0
Total 132,089 100.0 1,485 169.6
â€˜¿Adjustedby the direct method to age distribution of total study women.
Key AR = Relative Risk
AR = Attributable Risk Percent
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eliminated. This is a less useful concept.
however, since some risk factors represent
â€˜¿exposuresâ€•that can be modified or elim
inated (such as diet, alcohol consumption.
and excess weight), while others may not
be subject to such control (age at men
arche, family history. etc.).
What is of primary importance is that
the ARs are additive (see Table 2). The
total AR in the 30-to-54-year-old group is
21.1 percent. while in the 55-to-84-year
old group. it is 29.0 percent. This means
that, given our current understanding of
breast cancer risk factors, we are unable
to identify or account for the â€œ¿causesâ€•of
more than about one quarter of all cases.
Table 3 shows the RR for breast cancer
in women with specific risk factors as de
It looks as if the
clinician must consider every
female patient of 35 or older as
one at substantial risk of
developing breast cancer.
finedabove.Sinceclosetoonethirdofthe
women in our study population had more
than one risk factor, we calculated inci
dence rates and RRs in subgroups of
women with various combinations of fac
tors. The RR associated with each labeled
risk factor is shown for four groups of
women:
â€¢¿those who possess that factor, regardless
of any other factors they may have
â€¢¿those who possess that factor only, and
no other factors
â€¢¿those with that factor and exactly one
other factor
â€¢¿those with the given risk factor and at
least two other factors.
The most remarkable feature of the
graph is its lack of remarkabilityâ€”that is,
the majority of factors are associated with
risks of 1.8 or less.
The largest RR seen is 3.5. This RR
was found for one risk factor in each in
both of the age groups consideredâ€”i.e.,
women aged 30 to 54 with a family history
of breast cancer and two or more other risk
factors, and women aged 55 to 84 with a
history of a breast operation (as an index
of benign breast disease) and at least two
other factors. This latter risk factor appears
to be the strongest of those we considered,
because an RR of 3.4 was also found for
it in association with only one other risk
factor among the older women, and an RR
of 3.3 was seen among the younger women
with two or more other risk factors.
History of breast operation more than
doubled the risk in younger women and
nearly tripled it in older women. However,
because about one in 50 women possesses
this risk factor, it accounts for at most only
about three percent of the total number of
breast cancer cases.
Family history of breast cancer pro
duces the next highest RR in both age
groups; the incidence of breast cancer is
about triple the rate in the four to five per
cent of women with a family history. com
pared with women with no risk factors.
Surveillance is greatest in these two groups
of women with the highest RRs (family
history and history of breast operation).
which may lead to a better approximation
of their actual breast cancer risk. Because
these factors are those that are mostly ge
netically determined and thus not subject
to preventive measures, these women should
indeed receive a great deal of monitoring.
Discussion
Many advances have been made in our
understandingand treatmentof cancer.
Many people have quit or never started
smoking. and screening for cervical cancer
has become a routinepartof a woman's
annual checkup. Nonetheless, major dif
ficulties still obstruct our goal of more
widespread prevention. Even when epi
demiologists uncover major risk factors for
some cancers, such as those associated
with smoking exposure. inertia and indif
ference often reduce the potential success
of control efforts.
In the case of breast cancer, the risk
factors neither present as great a potential
for control nor are as clear-cut as those for
lung or cervical cancer. Investigators con
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women with a family history of breast can
cer, nulliparity, late age at first birth, and
lienign breast disease. These are factors
over which a woman has little or no con
trol. A factor over which the high-risk
women have some control is excessive rel
ative weight (particularly among older
women).
The results of this analysis seem to
correspond more with earlier reports than
recent ones stating that certain risk factors
hold â€œ¿thekeyâ€•to the understanding of the
etiology of breast cancer.707' That is, when
we considered the risk factors alone or in
combination, they explained only 21 per
cent of the breast cancer risk among
women aged 30 to 54 and 29 percent
among women aged 55 to 84. Different
choices and definitions of the risk factors
lead to somewhat different specific figures
but to the same general results. Further
effort might delineate combinations of spe
cific factors that could lead to even greater
risks, but such specific combinations occur
in relatively few women.
Despite our efforts to determine risk
factors for breast cancer, we have not ap
preciably increased our ability to identify
substantial numbers of truly â€œ¿high-riskâ€•
women. From thepointofviewofthecli
nician, all women should be treated as
being at appreciable risk for breast cancer:
which is not to say that it may not be useful
to single out specific women as at espe
References
cially â€œ¿highrisk.â€•From the point of view
of prevention, even small identifiable at
tributable risks, such as we have delineated
here. represent significant numbers of
cases of breast cancer.
The fact that three quarters of all breast
cancer cannot yet be attributed to any
known specific causes is reason to increase
our efforts to identify and quantify risk
factors, and to seek effective means of in
tervention and control.
Since the principles of prevention of
breast cancer are complicated and still in
an embryonic stage, women are fortunate
that early detection has proved so benefi
cial. Early detection of breast lesions has
led to both increased survival rates and
better quality of life for women with the
disease. Even if more data are amassed to
provide a better description of the truly
high-risk woman, it seems likely that such
women will constitute only a small pro
portion of total breast cancer cases. Women
should be taught breast self-examination
and encouraged to have periodic mam
mograms.
If the state of our knowledge does not
permit us to claim means of reducing the
incidence of breast cancer, at least we can
claim means of providing better outcomes
through earlier detection to those in whom
the disease was not prevented. Such news
should provide all women with the comfort
of knowing that they can take an active
role in their health.
I. American Cancer Society: Cancer Facts and
Figures, 1982. New York. American Cancer
Society Inc. 1982.
2. Lane-ClayponJE:A furtherreportoncancer
of the breast, with special reference to its as
sociated antecedent conditions, in Reports of
the Ministry of Health: Public Health and Med
ical Subjects No. 32. London. British Ministry
of Health, 1926.
3. MacMahon B. Cole P. Brown I: Etiolo
gy of human breast cancer: a review. INCI
50:21â€”42.1973.
4. Wynder EL, MacCornack FA, Stellman
SD: The epidemiology of breast cancer in
785 United States Caucasian women. Cancer
41:2341â€”2354. 1978.
5. KelseyIL: A reviewof the epidemiologyof
human breast cancers. Epidemiol Rev 1:74â€”109.
1979.
6. Miller AB. Bulbrook RD: The epidemiology
and etiology of breast cancer. N Engl I Med
303:1246â€”1248. 1980.
7. Anderson DE: Some characteristicsof fa
milial breast cancer. Cancer 28:1500â€”1504.
1971.
8. Lilienfeld AM: The epidemiology of breast
cancer. Cancer Res 23:1503â€”1513.1963.
9. Petrakis NL: Genetic factors in the etiology
of breast cancer. Cancer 39:2709â€”2715.1977.
VOL 32. NO 5 SEPTEMBER'OCTOBER 1982 311
 by on S
eptem












10. Slaber EJ, Trichopoulos D, MacMahon B:
Lactation and reproductive histories of breast
cancer patients in Boston, 1965â€”1966. JNCI
43:1013â€”1024, 1969.
11. Wynder EL, Bross IDJ, Hirayama T: A
study of the epidemiology of cancer of the
breast. Cancer 13:559â€”601,1960.
12. Staszewski J: Age at menarche and breast
cancer. JNCI 47:935â€”940, 1971.
13. Trichopoulos D, MacMahon B, Cole P:
Menopause and breast cancer risk. JNCI
48:60@â€”6l3,1972.
14. Lew EA, Garfinkel L: Variations in mor
tality .by weight among 750,000 men and
women. J Chronic Dis 32:563â€”576,1979.
15. De Waard F: Breast cancer incidence
and nutritional status with particular reference
to body weight and height. Cancer Res
35:3351â€”3356, 1975.
16. De Waard F, Baanders-van Halewijn EA:
A prospective study in general practice on breast
cancer risk in postmenopausal women. Int J
Cancer 14:153â€”160, 1974.
17. MacKenzie I: Breast cancer following mul
tiple fluoroscopies. Br J Cancer 19:1â€”8,1965.
18. -Wanebo CK, Johnson KG, Sato H, et al:
Breast cancer after exposure to the atomic
bombings of Hiroshima and Nagasaki. N EngI
J Med 279:667â€”671,1968.
19. Myrden JA. Hiltz JE: Breast cancer fol
lowing multiple fluoroscopies during artificial
pneumothorax treatment of- pulmonary tuber
culoses. Can Med Assoc J lOO:l032-'1034,
1969.
20. Jablon S. Kato H: Studies of the mortality
of A-bomb survivors: 5. Radiation dose and
mortality, 1950â€”1970.Radiat Res 50:649â€”698,
1972.
21. McGregor DH, Land CE, Choi K. et al:
Breast cancer incidence among atomic bomb
survivors, Hiroshima and Nagasaki, 1950-1969.
JNCI 59:799â€”811, 1977.
22. Shore RE, Hempelmann LH, Kowaluk E.
et al: Breast neoplasms in women treated with
x-rays for acute postpartum mastitis. JNCI
59:813â€”822, 1977.
23. Alcantara EN, Speckman EW: Diet, nutri
tion, and cancer. Am J Clin Nutr 29:1035â€”1047,
1976.
24. Armstrong B, Doll R: Environmental fac
tors and cancer incidence and mortality in dif
ferent countries, with special reference to di
etary practices. Int J Cancer 15:627â€”631,1975.
25. Carroll KK, Gammal EB, Plunkett ER:
Dietary fat and mammary cancer. Can Med
Assoc J 98:590â€”594, 1968.
26. Miller AB: Role of nutrition in the etiology
of breast cancer. Cancer 39:2704â€”2708, 1977.
27. Gaskill SP, McGuire WL, Osborne CK,
et al: Breast cancer mortality and diet in the
United States. Cancer Res 39:3628â€”3637,
1979.
28. Miller AB, Kelly A, Choi NW. et al: A
study of diet and breast cancer. Am J Epidemiol
107:499â€”509, 1978.
29. Hankin JH, Rawlings V: Diet and breast
cancer: a review. Am J Clin Nutr 31:2007â€”2016,
1978.
30.Graham S. MarshallJ.MettlinC. etal:
Diet in the epidemiology of breast cancer. Am
J Epidemiol 116:68â€”75,1982.
31. Rosenberg L. Slone D, Shapiro S. et al:
Breast cancer and alcoholic beverage consump
tion. Lancet 1:267â€”270.1982.
32. Hoover R, Gray L, Cole P. et al: Meno
pausal estrogens and breast cancer. N Engl J
Med 295:401â€”405, 1976.
33. Ross RK, Paganini-Hill A, Gerkins yR.
et al: A case-control study of menopausal es
trogen therapy and breast cancer. JAMA
243:1635â€”1639, 1980.
34. Brinton LA. Hoover RN. Szklo M. et al:
Menopausal estrogen use and risk of breast can
cer. Cancer 47:2517â€”2522. 1981.
35. Jick H, Walker AM, Watkins RN, et al:
Replacement estrogens and breast cancer. Am
J Epidemiol 112:586â€”594,1980.
36. Lubin JH, Burns PE, Blot Wi, et al: Risk
factors for breast cancer in women in northern
Alberta, Canada, as related to age at diagnosis.
JNCI 68:211â€”217, 1982.
37. Pike MC, Henderson BE, Casagrande iT,
et al:.Oral contraceptive use and early abortion
as risk factors for breast cancer in young
women. Bri Cancer 43:72â€”76.1981.
38. Trapido El: A prospective cohort study of
oral contraceptives and breast cancer. JNCI
67:1011â€”1015, 1981.
39. Vessey MP. Doll R. Jones K. Ct al: An
epidemiologic study of oral contraceptives and
breast cancer. Br Med J 1:1757â€”1760.1979.
40. Arthes FG, Sartwell PE, Lewison EF: The
pill, estrogens, and the breast: epidemiologic
aspects. Cancer 28:1391â€”1394, 1971.
41. Henderson BE, Powell D, Rosario I, et al:
An epidemiologic study of breast cancer. JNCI
53:609â€”614, 1974.
42. Fasal E, Paffenbarger RS: Oral contracep
tives as related to cancer and benign lesions of
the breast. JNCI 55:767â€”773,1975.
43. Kelsey J, Holford TR, White C. et al: Oral
contraceptives and breast disease. Am J Epi
demiol 107:236â€”244,1978.
44. Vessey MP. Doll R, Sutton PM: Oral con
traceptives and breast neoplasia: a retrospective
study. Br Med J 3:719â€”724,1972.
45. Paffenbarger RS, Fasal E. Simmons
ME, et al: Cancer risk as related to use of oral
312 CA-A CANCERJOURNALFORCLINICIANS
 by on S
eptem












and breast cancer: a community-based longi
tudinal study of 2,000 hypertensive women.
JAMA 243:2304â€”2310, 1980.
60. Seidman H: Statistical and epidemiological
data on cancer of the breast. New York, Amer
ican Cancer Society Inc. 1979.
61. Seidman H: Screening for breast cancer in
younger women: life expectancy gains and
losses. CA 27:66â€”87.1977.
62. Hammond EC: Some preliminary findings
on physical complaints from a prospective study
of 1.064,004 men and women. Am J Public
Health 54:11â€”23,1964.
63. Hammond EC: Smoking in relation to the
death rates of one million men and women. NCI
Monogr 19:127â€”204.1966.
64. Hammond EC. GartmnkelL: The influence
of health on smoking habits. NCI Monogr
19:269â€”285,1966.
65. Hammond EC, Garfinkel L: Coronary
heart disease, stroke, and aortic aneurysm: fac
tors in the etiology. Arch Environ Health
19:167â€”182,1969.
66. Hammond EC, Garfinkel L. Seidman H.
et al: â€œ¿Tarâ€•nd nicotine content of cigarette
smoke in relation to death rates. Environ Res
12:263â€”274,1976.
67. Hammond EC. Selikoff IJ. Seidman H:
Asbestos exposure. cigarette smoking. and
death rates. Ann NY Acad Sci 330:473â€”490,
1979.
68.De WaardF,Baanders-vanHalewijnEA.
Huizinga J: The bimodal age distribution of
patients with mammary carcinoma: evidence for
existence of two types of human breast cancer.
Cancer 17:141â€”151,1964.
69. Stavraky K, Emmons 5: Breast cancer in
premenopausal and postmenopausal women.
JNCI 53:647â€”654.1974.
70. Wynder EL: Identification of women
at high risk for breast cancer. Cancer
24:1235â€”1240, 1969.
71. Henderson BE. Pike MC. Ross RK: Epi
demiology of breast cancer, in Feig SA. Mclel
land R (eds): Breast Carcinoma: Current Di
agnosis and Treatment. New York. Masson
Publishers, 1982.
contraceptives during fertile years. Cancer
39:1887â€”1891, 1971.
46. Lees AW, Burns PE, Grace M: Oral con
traceptives and breast disease in premenopausal
northern Albertan women. mt i Cancer
22:700â€”707,1978.
47. Shore RE, Pasternak BS. Thiessen EU, et
al: A case-control study of hair dye use and
breast cancer. JNCI 62:277â€”283,1979.
48. Kinlen Li, Harris R, Garrod A, et al: Use
of hair dyes by patients with breast cancer: a
case-control study. Br Mcdi 2:366â€”368.1977.
49. Hennekens CH, Speizer FE, Rosner B. et
al: Hair dyes and human cancer, abstracted. Am
J Epidemiol 108:240â€”241,1978.
50. Shafer N, Shafer RW: Potential of carci
nogenic effects of hair dyes. NY State J Med
76:394â€”396, 1976.
51. Boston Collaborative Drug Surveillance
Program: Reserpine and breast cancer. Lancet
2:669â€”671, 1974.
52. Armstrong B, Stevens N, Doll R: Retro
spective study of the association between use
of Rauwolfia derivatives and breast cancer in
English women. Lancet 2:672â€”675,1974.
53. Heinonen OP. Shapiro S. Tuominen L. et
al: Reserpine use in relation to breast cancer.
Lancet 2:675â€”677,1974.
54. Williams RR, Feinleib M, Connor Ri, et
al: Case-cÃ¸ntrol study of antihypertensive and
diuretic use by women with malignant and be
nign breast lesions detected in a mammography
screening program. JNCI 61:327â€”335,1978.
55. Laska EM, Siegel C, Meisner M, et al:
Matched-pairs study of reserpine use and breast
cancer: Lancet 2:296â€”300,1975.
56. Lilienfeld AM, Chang L, Thomas DB, et
al: Rauwolfia derivatives and breast cancer.
iohns Hopkins Med Jl39:4lâ€”5O. 1976.
57. O'Fallon WM. Labarthe DR. Kurland LT:
Rauwoltia derivatives and breast cancer: a case
control study in Olmstead County. Minnesota.
Lancet 2:292â€”296.1975.
58. Armstrong B. Skegg D. White G. et al:
Rauwolfia derivatives and breast cancer in hy
pertensive women. Lancet 2:8â€”12. 1976.
59. Labarthe DR. O'Fallon WM: Reserpine
VOL. 32, NO. 5 SEPTEMBER/OCTOBER1982 313
 by on S
eptem
ber 22, 2009 (©
A
m
erican C
ancer S
ociety, Inc.) 
caonline.am
cancersoc.org
D
ow
nloaded from
 
